Lightpoint Medical was founded in 2012 with the goal of becoming the world technology leader in targeted cancer surgery. The company’s technology has the potential to detect cancer in real time during surgery, enabling surgeons to remove the cancerous tissue while sparing healthy tissue. The technology is based on administering the patient a cancer-targeted imaging drug and then detecting the cancer live during surgery.

Since the founding of the company, Lightpoint has achieved clinical trial data in multiple cancer types, regulatory clearance, and is well on its way to transforming the practice of cancer surgery.

We invite you to learn more about our technology.